Glass House Brands (GLAS) Interest Coverage Ratio (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Interest Coverage Ratio of 11.08 for Q1 2026, down 229.91% quarter-over-quarter from 8.53 in Q4 2025.

Glass House Brands (GLAS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Interest Coverage Ratio for 7 consecutive years, with 11.08 the latest figure, recorded in Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 11.08; the TTM figure through Mar 2026 stood at 7.83 (changed N/A YoY), while the FY2025 annual figure was 0.4, down 380.41% from the prior year.
Interest Coverage Ratio eased to 11.08 in Q1 2026 per GLAS's latest filing, from 8.53 in the prior quarter.
Across five years, Interest Coverage Ratio topped out at 15.32 in Q1 2023 and bottomed at 11.49 in Q1 2022.
Historically, Interest Coverage Ratio has averaged 1.6 across 5 years, with a median of 1.61 in 2023.
On a YoY basis, Interest Coverage Ratio climbed as much as 803.06% in 2022 and fell as far as 134.14% in 2022.
Glass House Brands' Interest Coverage Ratio stood at 7.61 in 2022, then tumbled by 91.0% to 0.68 in 2023, then surged by 184.03% to 1.94 in 2024, then surged by 338.59% to 8.53 in 2025, then tumbled by 229.91% to 11.08 in 2026.
Business Quant data shows GLAS's Interest Coverage Ratio at 11.08 in Q1 2026, 8.53 in Q4 2025, and 6.26 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	-
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn	114.07
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Glass House Brands	825.81 Mn	807.26 Mn	15.77 Mn	-4.77

Download Data